Trials / Completed
CompletedNCT01784614
A Study of LY2624803 in Japanese Participants With Transient Insomnia
Pharmacodynamics and Pharmacokinetics of Single Doses of LY2624803 in a 5-hour Phase Advance Model of Transient Insomnia in Healthy Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to learn how different doses of LY2624803 affect sleep in healthy Japanese participants. The study has four treatment periods. Participants will receive a single dose of LY2624803 or placebo in each treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY2624803 - Solution | Administered orally as reconstituted solution |
| DRUG | LY2624803 - Capsule | Administered orally as a capsule |
| DRUG | Placebo - Solution | Administered orally as solution |
| DRUG | Placebo - Capsule | Administered orally as a capsule |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2013-02-06
- Last updated
- 2016-01-28
- Results posted
- 2016-01-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01784614. Inclusion in this directory is not an endorsement.